Pfizer raises stakes with final AstraZeneca takeover approach

New £69.4bn proposal, worth £55 a share, piles pressure on AstraZeneca’s board to enter negotiations

US drugsmaker Pfizer has raised the stakes in its much-contested quest to buy British rival AstraZeneca by lodging a fresh £69bn takeover approach.

The new proposal of £55 a share piles pressure on AstraZeneca’s board to enter negotiations to create the world’s largest pharmaceutical company in the face of considerable opposition from politicians and Britain’s scientific community.

Continue reading…
Pharmaceuticals industry | The Guardian

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us